European Pharmaceutical Journal (Apr 2022)

The Evaluation of Cardiovascular Risk in Diabetic Patients

Kosirova S.,
Rubintova D.,
Lacka J.,
Klimas J.,
Foltanova T.,
Tumova I.

Affiliations

Kosirova S.: Comenius University Bratislava, Faculty of Pharmacy, Bratislava, SLOVAKIA
Rubintova D.: Pharmacy Marianum, Trnava, Slovakia
Lacka J.: Diabetologic ambulance, Trnava, Slovakia
Klimas J.: Comenius University Bratislava, Faculty of Pharmacy, Bratislava, SLOVAKIA
Foltanova T.: Comenius University Bratislava, Faculty of Pharmacy, Bratislava, SLOVAKIA
Tumova I.: Comenius University Bratislava, Faculty of Pharmacy, Bratislava, SLOVAKIA

DOI: https://doi.org/10.2478/afpuc-2022-0001
Journal volume & issue: Vol. 69, no. 1
pp. 1 – 8

Abstract

The aim of the study was to evaluate cardiovascular risk in patients with diabetes mellitus type 2 according to gender.

Published in European Pharmaceutical Journal

ISSN: 2453-6725 (Online)
Publisher: Sciendo
Country of publisher: Poland
LCC subjects: Medicine: Therapeutics. Pharmacology
Website: https://sciendo.com/journal/AFPUC

About the journal